GP
Girish Paman Vanvari
About Girish Paman Vanvari
Data last updated:
Girish Paman Vanvari is a Director at Aurobindo Pharma Ltd (since 2020), Director at Cmr Green Technologies Limited (since 2025) and Director at Himadri Speciality Chemical Limited (since 2021), and holds 8 more current directorships. The companies operate in Pharma, Metals and Minerals and Chemicals and Materials. The 9 current companies with reported revenue have a combined latest revenue of ₹50,923 Cr; the largest is Aurobindo Pharma Ltd at ₹34,145 Cr (FY 2026). Earlier, Girish Paman Vanvari was a Director at Tarsons Products Limited (2021–2026) and Designated Partner at Abcd Technologies Llp (2021–2023) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Nov 2020 | 1986 | ₹34,145 Cr (FY 2026) | Active | |
| Director | 09 Jun 2025 | 2005 | ₹6,699 Cr (FY 2025) | Active | |
| Director | 22 Jun 2021 | 1987 | ₹4,832 Cr (FY 2026) | Active | |
| Director | 29 Jun 2021 | 2012 | ₹1,885 Cr (FY 2026) | Active | |
| Director | 29 Jul 2021 | 1991 | ₹1,395 Cr (FY 2024) | Active | |
| Director | 13 Apr 2022 | 1968 | ₹1,076 Cr (FY 2025) | Active | |
| Director | 01 Jun 2023 | 2018 | ₹757 Cr (FY 2026) | Active | |
| Designated Partner | 24 Apr 2018 | 2018 | ₹75.22 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 May 2021 | 1983 | ₹408 Cr (FY 2025) | Active | |
| Designated Partner | 10 Feb 2021 | 2021 | Active | ||
| Designated Partner | 15 Mar 2021 | 2021 | ₹38.02 Cr (FY 2023) | Active | |
| Director | 06 Sep 2021 | 1951 | ₹977 Cr (FY 2025) | Active | |
| Partner | 01 Mar 2015 | 2010 | ₹922 Cr (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Girish Paman Vanvari
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Girish Paman Vanvari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Girish Paman Vanvari
Girish Paman Vanvari currently holds 11 directorships: Aurobindo Pharma Ltd (Director, since 05 Nov 2020, revenue ₹34,145 Cr (FY 2026)); Cmr Green Technologies Limited (Director, since 09 Jun 2025, revenue ₹6,699 Cr (FY 2025)); Himadri Speciality Chemical Limited (Director, since 22 Jun 2021, revenue ₹4,832 Cr (FY 2026)); Rategain Travel Technologies Limited (Director, since 29 Jun 2021, revenue ₹1,885 Cr (FY 2026)); Kolte-Patil Developers Limited (Director, since 29 Jul 2021, revenue ₹1,395 Cr (FY 2024)); and 6 more.
Girish Paman Vanvari was first appointed on 01 Mar 2015 as Partner at Kpmg India Services Llp. The most recent appointment on record is 24 Feb 2026 at Suzlon Energy Limited.
The 9 current companies of Girish Paman Vanvari that report revenue have a combined latest revenue of ₹50,923 Cr: Aurobindo Pharma Ltd ₹34,145 Cr (FY 2026); Cmr Green Technologies Limited ₹6,699 Cr (FY 2025); Himadri Speciality Chemical Limited ₹4,832 Cr (FY 2026); Rategain Travel Technologies Limited ₹1,885 Cr (FY 2026); Kolte-Patil Developers Limited ₹1,395 Cr (FY 2024); and 4 more.
Girish Paman Vanvari held 5 earlier board appointments: Tarsons Products Limited (Director, 10 May 2021 to 06 Feb 2026); Abcd Technologies Llp (Designated Partner, 10 Feb 2021 to 01 Dec 2023); Aarogya Bharat Digital Llp (Designated Partner, 15 Mar 2021 to 30 Nov 2023); Avon Cycles Ltd (Director, 06 Sep 2021 to 13 Feb 2024); Kpmg India Services Llp (Partner, 01 Mar 2015 to 31 Mar 2018).
The current boards of Girish Paman Vanvari's companies include Adi Reddy Baddigam (Aurobindo Pharma Ltd), Madan Mohan Reddy Mettu (Aurobindo Pharma Ltd), Mangalam Ramasubramanian Kumar (Aurobindo Pharma Ltd), Nityananda Reddy Kambam (Aurobindo Pharma Ltd), Punita Kumar Sinha (Aurobindo Pharma Ltd), Santanu Mukherjee (Aurobindo Pharma Ltd), among others.